PLEC-EIF2AK2 Fusion FISH Probe
The PLEC-EIF2AK2 Fusion FISH Probe is used to confirm a fusion of the PLEC and EIF2AK2 genes. The fusion of the PLEC and EIF2AK2 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
PLEC-EIF2AK2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-RERE | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-REOR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-REGO | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-REGR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-REAQ | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-ORRE | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-OROR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-ORGO | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-ORAQ | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GORE | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GOOR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GOGO | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GOGR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GOAQ | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GRRE | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GROR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GRGO | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GRGR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-GRAQ | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-AQRE | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-AQOR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-AQGO | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-AQGR | 20 (40 μL) | 200 μL | ||
PLEC-EIF2AK2-20-AQAQ | 20 (40 μL) | 200 μL |
PLEC Gene Summary
Plectin is a prominent member of an important family of structurally and in part functionally related proteins, termed plakins or cytolinkers, that are capable of interlinking different elements of the cytoskeleton. Plakins, with their multi-domain structure and enormous size, not only play crucial roles in maintaining cell and tissue integrity and orchestrating dynamic changes in cytoarchitecture and cell shape, but also serve as scaffolding platforms for the assembly, positioning, and regulation of signaling complexes (reviewed in PMID: 9701547, 11854008, and 17499243). Plectin is expressed as several protein isoforms in a wide range of cell types and tissues from a single gene located on chromosome 8 in humans (PMID: 8633055, 8698233). Until 2010, this locus was named plectin 1 (symbol PLEC1 in human; Plec1 in mouse and rat) and the gene product had been referred to as "hemidesmosomal protein 1" or "plectin 1, intermediate filament binding 500kDa". These names were superseded by plectin. The plectin gene locus in mouse on chromosome 15 has been analyzed in detail (PMID: 10556294, 14559777), revealing a genomic exon-intron organization with well over 40 exons spanning over 62 kb and an unusual 5' transcript complexity of plectin isoforms. Eleven exons (1-1j) have been identified that alternatively splice directly into a common exon 2 which is the first exon to encode plectin's highly conserved actin binding domain (ABD). Three additional exons (-1, 0a, and 0) splice into an alternative first coding exon (1c), and two additional exons (2alpha and 3alpha) are optionally spliced within the exons encoding the acting binding domain (exons 2-8). Analysis of the human locus has identified eight of the eleven alternative 5' exons found in mouse and rat (PMID: 14672974); exons 1i, 1j and 1h have not been confirmed in human. Furthermore, isoforms lacking the central rod domain encoded by exon 31 have been detected in mouse (PMID:10556294), rat (PMID: 9177781), and human (PMID: 11441066, 10780662, 20052759). The short alternative amino-terminal sequences encoded by the different first exons direct the targeting of the various isoforms to distinct subcellular locations (PMID: 14559777). As the expression of specific plectin isoforms was found to be dependent on cell type (tissue) and stage of development (PMID: 10556294, 12542521, 17389230) it appears that each cell type (tissue) contains a unique set (proportion and composition) of plectin isoforms, as if custom-made for specific requirements of the particular cells. Concordantly, individual isoforms were found to carry out distinct and specific functions (PMID: 14559777, 12542521, 18541706). In 1996, a number of groups reported that patients suffering from epidermolysis bullosa simplex with muscular dystrophy (EBS-MD) lacked plectin expression in skin and muscle tissues due to defects in the plectin gene (PMID: 8698233, 8941634, 8636409, 8894687, 8696340). Two other subtypes of plectin-related EBS have been described: EBS-pyloric atresia (PA) and EBS-Ogna. For reviews of plectin-related diseases see PMID: 15810881, 19945614. Mutations in the plectin gene related to human diseases should be named based on the position in NM_000445 (variant 1, isoform 1c), unless the mutation is located within one of the other alternative first exons, in which case the position in the respective Reference Sequence should be used. [provided by RefSeq, Aug 2011]
Gene Name: Plectin
Chromosome: CHR8: 144989320 -145050913
Locus: 8q24.3
EIF2AK2 Gene Summary
The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
Gene Name: Eukaryotic Translation Initiation Factor 2 Alpha Kinase 2
Chromosome: CHR2: 37333698 -37384190
Locus: 2p22.2
Gene Diseases
The PLEC EIF2AK2 Fusion has been associated with the following diseases:
Disease Name |
---|
Lung Adenocarcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|